What changed
Adjusted EPS of $2.29 beat consensus of $2.20 by $0.09, or +4.1%. Revenue quality is solid, driven by system-wide RevPAR growth of 3.9% on broad-based demand, with management and franchise fees up 6.4%. Full-year RevPAR guidance of 3.0%-3.5% and Adj. EBITDA of $4.04B-$4.08B imply continued momentum. The key nuance: net unit growth of 6.1% and a record pipeline of 541K rooms signal accelerating development, a durable driver beyond transient RevPAR trends.
Why it matters
Adjusted EPS of $2.29 beat consensus of $2.20 by $0.09, or +4.1%. Revenue quality is solid, driven by system-wide RevPAR growth of 3.9% on broad-based demand, with management and franchise fees up 6.4%. Full-year RevPAR guidance of 3.0%-3.5% and Adj. EBITDA of $4.04B-$4.08B imply continued momentum. The key nuance: net unit growth of 6.1% and a record pipeline of 541K rooms signal accelerating development, a durable driver beyond transient RevPAR trends.